Endourology and Stone Disease
Why Yale UrologyYale Urology’s Stone Program offers a multidisciplinary, comprehensive approach to treating kidney stones in both adults and children. We are committed to offering our patients the most advanced diagnostic technologies and treatment strategies available. Our doctors continually integrate the latest in science-based medicine and innovative approaches into their practice to offer patients safer and more effective treatments.
Innovative TreatmentsOur team uses non-invasive radiologic imaging, such as ultrasounds and CT scans to identify and quantify the stone burden. We use state-of-the-art treatment modalities, including incisionless stone ablation with shock waves and minimally invasive approaches using endoscopic or percutaneous techniques to break up and extract the stones. Some stones can be treated with non-invasive medical management.
Yale Leads the Way
Yale University and the Stone Research Team, which is a multidisciplinary collaboration between urology, emergency medicine, biostatistics, and radiology, has been leading the way in reducing radiation exposure for patients presenting with kidney stones. Such patients are most risk for cumulative radiation exposure since they are more prone to recurrent stones and pain, and thus subjected to more imaging. Radiation dosing has risks for the development of secondary cancers. In fact, it is estimated that 29,000 patients in the United States will acquire a secondary cancer as a result of CT scan-induced radiation exposure. For example, for every 500 – 1400 CT scans done for kidney stones, one patient will develop a secondary cancer. We are testing the use of an Ultra Low Dose CT scan, which is approximately 87% less radiation than the standard CT scans that are done for patients with kidney stones.
We have also formed a multidisciplinary team, consisting of urology, nephrology, and dietary experts, to work with patients to reduce future kidney stones. Once someone has formed a kidney stone, their risks of getting another one within 10 years is 50%, and that is too high. We are dedicated to working with patients to lower that percentage chance to as low a number as possible. This is a new program at Yale and is the core of the Yale Stone Clinic.